Država: Avstralija
Jezik: angleščina
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
PIMOBENDAN
AVET HEALTH LIMITED
PARENTERAL LIQUID/SOLUTION/SUSPENSION
PIMOBENDAN PYRIDAZINONE Active 0.75 mg/ml
10 mL; 5 mL
VM - Veterinary Medicine
CARDIOVASCULAR SYSTEM
Poison schedule: 4; Withholding period: N/A N/A; Host/pest details: DOG: [CONGESTIVE HEART FAILURE]
Registered
2023-07-01
[Wagg & Purr] Pimobendan 0.75 mg/mL Injectable Solution for Dogs 92877/137035 Product Name: APVMA Approval No: Label Name: [Wagg & Purr] Pimobendan 0.75 mg/mL Injectable Solution for Dogs Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: 0.75 mg/mL Pimobendan Claims: To initiate treatment of congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid regurgitation) in dogs. For use only by or under supervision of a veterinarian. Net Contents: 5 mL 10 mL Directions for Use: Restraints: Contraindications: Contraindicated for use in animals with hypertrophic cardiomyopathies or clinical conditions where an augmentation of cardiac output is not possible for functional or anatomical reasons (e.g. aortic stenosis). Contraindicated for use in dogs not showing signs of cardiac disease. Precautions: Use with caution in pregnant, lactating and breeding dogs. In studies with rats and rabbits, pimobendan had no effect on fertility and embryotoxic effects only occurred at maternotoxic doses. In rat experiments, it has been shown that pimobendan is excreted into the milk. [Wagg & Purr] Pimobendan 0.75 mg/mL Injectable Solution for Dogs should only be used administered to pregnant and lactating bitches if the expected therapeutic benefits outweigh the potential risk. RLP APPROVED Studies into the effect of pimobendan on the reproductive function of male dogs have not been conducted. Side Effects: A moderate positive chronotropic effect and vomiting may occur in rare cases. In rare cases transient diarrhoea, anorexia or lethargy have been observed. In the event of accidental subcutaneous injection, temporary swelling and mild resorptive inflammatory reactions may occur at or below the injection site. Overdose In case of overdosing symptomatic treatment should be initiated. Dosage and Administration: Single use only. Use immediately after opening. Discard the unused portion of the product immediately a Preberite celoten dokument